Effects of ursodeoxycholic acid on target apoptosis induced by an antigen-specific CD4+-T cell line

International Hepatology Communications

Volumn 4, Issue 5, 1996, Pages 268-276

  Yoshikawa, Masahide ^a   Matsui, Yuji ^a   Umemoto, Norie ^a   Yamao, Junichi ^a   Kuriyama, Shigeki ^a   Fukui, Hiroshi ^a   Nakano, Hiroshi ^a   Hozumi, Nobumichi ^b   Tsujii, Tadasu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antigen presentation; Antigen processing; Apoptosis; T cell cytotoxicity; Ursodeoxycholic acid

Indexed keywords

DNA FRAGMENT; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CYTOTOXICITY; ETIOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029988173     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-4346(96)00255-1     Document Type: Article

References (20)

1. Poupon RE, Poupon R, Balkau B, the UDCA-PBC Study Group. Ursodior for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-1347.
2. Heathcote EJ, Cauch-Dudek K, Walker V et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-1156.
3. Lindor KD, Dickson ER, Baldus WP et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-1290.
4. Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Ursodeoxycholic acid, taurine or a combination of the two for chronic hepatitis. Gastroenterology 1990; 98: 1044-1050.
5. Bellantani S, Tabarroni G, Barchi T et al. Effect of ursodeoxycholic acid treatment on alanine aminotransferase and γ-glutamyltranspeptidase serum levels in patients with hypertranseaminasemia. J Hepatol 1989; 8: 7-12.
6. Takano S, Ito Y, Yokosuka O et al. A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C. Hepatology 1994; 20: 558-564.
7. Calmus Y, Weil B, Ozier Y, Chereau C, Houssin D, Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 1992; 103: 617-621.
8. Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993; 18: 165-172.
9. Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 1992; 16: 719-723.
10. Yoshikawa M, Tsujii T, Matsumura K et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992; 16: 358-364.
11. Hiramatsu N, Hayashi N, Katayama K et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-1359.
12. Okazaki M, Hino K, Fujii K et al. Immunohistochemical study of Fas antigen in liver of patients with chronic hepatitis and autoimmune liver disease. Int Hepatol Commun 1995; 3: 285-289.
13. Watanabe M, Wegmann DR, Ochi A, Hozumi N. Antigen presentation by a B-cell line transfected with cloned immunoglobulin heavy- and light-chain genes specific for a defined hapten. Proc Natl Acad Sci USA 1986; 83: 5247-5251.
14. Watanabe M, Yoshikawa M, Hozumi N. Cytotoxic function of a cloned helper T cell line. Immunol Lett 1987; 15: 133-138.
15. Yamanaka M, Oto M, Obata H et al. The examination of the therapeutic efficacy of ursodeoxy-cholic acid on chronic hepatitis: a double-blind study (in Japanese). Sindan to Chiryo 1976; 64: 2150-2157.
16. Yoshikawa M, Matsumura K, Matsumura Y et al. Effects of ursodeoxycholic acid on antigen presentation. Int Hepatol Commun 1993; 1: 243-249.
17. Searle J, Harmon BV, Bishop CJ, Kerr JFR. The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 1987; 2: 77-96.
18. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
19. + -T cell (in Japanese). Proc Jpn Soc Immunol 1994; 24: 433.
20. Takayama H, Kojima H, Shinohara N. Cytotoxic T lymphocytes: The newly identified Fas (CD95)-mediated killing mechanism and a novel aspect of their biological functions. Adv Immunol 1995; 60: 289-321.